The major European drug regulator, European Medicines Agency (EMA), started reviewing the Moderna COVID-19 vaccine for children aged from 6 to 11 years old, the agency announced on Wednesday.
The leading drug manufacturing corporation said that it officially applied to EMA to have authorization for their COVID-19 vaccine to be used for younger people.
Regarding the duration of the process, EMA said in a statement: "The current timeline for evaluation foresees an opinion in approximately two months unless supplementary information or analysis is needed."
It added: "This is a shortened timetable compared to similar types of reviews outside of a pandemic."
However, using the Moderna vaccine is still controversial in the 27-nation bloc as several European countries as France, and Germany restricted the usage of the vaccine for people aged above 30 due to concerns over rare side effects.
Until now, only the Pfizer vaccine proved its safety and effectiveness for children aged 5 years old, according to the US Food and Drug Authority (FDA).
After FDA's decision, several countries started to protect children, especially in schools, with the Pfizer vaccine.
Follow the latest news on Google News
